Immudex Takes On International Proficiency Panels

Copenhagen, Denmark, Mainz, Germany, and New York, USA - April 23, 2013 - Immudex has entered into a strategic agreement with the US Cancer Immunotherapy Consortium of the Cancer Research Institute, and the European Association for Cancer Immunotherapy , under which Immudex will provide MHC-peptide multimer and Elispot proficiency panel services ... (more)

http://www.newswise.com/articles/view/602147/?sc=rsmn&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+NewswiseMednews+%28Newswise%3A+MedNews%29